Nicolas Beauval

Université de Lille

Papers

1

Total Citations

1

H-Index

1

About

Nicolas Beauval is a researcher focused on the safety and quality of pharmaceutical compounding, particularly concerning hazardous drugs like cytotoxics. His work addresses critical challenges in hospital pharmacy practice, including the prevention of occupational exposure to antineoplastic agents. His most cited study, a 2024 pilot investigation, provides a rigorous assessment of chemical contamination during the use of the RIVA™ robotic compounding system. By measuring cytotoxic contamination both inside and outside the robot, Beauval’s research offers vital data on the effectiveness of robotic automation in reducing health risks for pharmacy staff. This contribution is especially significant as hospitals increasingly adopt robotic technology to enhance safety and precision. Though his citation count is still growing, his work is highly relevant to the fields of pharmaceutical technology, occupational health, and clinical pharmacy, helping to shape safer practices for the preparation of life-saving cancer therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Assessment of chemical contamination by cancer drugs during use of the RIVA <sup>TM</sup> compounding robot: A pilot study
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Université de Lille

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago